Vasodilatory mechanism of unoprostone isopropyl on isolated rabbit ciliary artery

Current Eye Research

Volumn 28, Issue 3, 2004, Pages 167-174

  Yoshitomi, Takeshi ^a   Yamaji, Kazutsuna ^b   Ishikawa, Hitoshi ^c   Ohnishi, Yoshitaka ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c International University of Health and Welfare   (Japan)

Author keywords

Adenylyl cyclase; Ciliary artery; Guanylyl cyclase; Isometric tension; M1; M2; Maxi K channels; Rabbit; Relaxation; Unoprostone; Vascular smooth muscle

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; DRUG METABOLITE; GUANYLATE CYCLASE; HISTAMINE; IBERIOTOXIN; POTASSIUM; POTASSIUM CHANNEL; PROSTAGLANDIN F2 ALPHA DERIVATIVE; UNOPROSTONE ISOPROPYL ESTER;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CILIARY ARTERY; CONTROLLED STUDY; DISSECTION; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME INHIBITION; EYE; GLAUCOMA; IN VITRO STUDY; INHIBITION KINETICS; MALE; MICROSCOPE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECORDING; SMOOTH MUSCLE RELAXATION; TENSION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ADENINE; ADENYLATE CYCLASE; ANIMALS; ANTIHYPERTENSIVE AGENTS; CILIARY ARTERIES; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GUANYLATE CYCLASE; HISTAMINE; ISOMETRIC CONTRACTION; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MUSCLE, SMOOTH, VASCULAR; OXADIAZOLES; PEPTIDES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; QUINOXALINES; RABBITS; VASODILATION;

EID: 1642363906     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.28.3.167.26249     Document Type: Article

References (39)

1. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol. 1994;38:Suppl:s3-s6.
2. Yamamoto T, Kitazawa Y. Vascular pathogenesis of normal-tension glaucoma: A possible pathogenetic factor, other than intraocular pressure, of glaucomatous optic neuropathy. Prog Retin Eye Res. 1998;17:127-143.
3. Anderson DR. Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma. Surv Ophthalmol. 1999;43:Suppl 1:s5-s9.
4. Tamaki Y, Araie M, Tomita K, Nagahara M, Tomidokoro A. Effect of topical β-blockers on tissue blood flow in the human optic nerve head. Curr Eye Res. 1997;16:1102-1110.
5. Hayashi-Morimoto R, Yoshitomi T, Ishikawa H, Hayashi E, Sato Y. Effects of β antagonists on mechanical properties in rabbit ciliary artery. Graefes Arch Clin Exp Ophthalmol. 1999;237:661-667.
6. Yoshitomi T, Yamaji K, Ishikawa H, Ohnishi Y. Vasodilatory effects of nipradilol, an alpha and β adrenergic blocker with nitric oxide releasing action, in rabbit ciliary artery. Exp Eye Res. 2002;75:669-676.
7. Azuma I, Masuda K, Kitazawa Y, Takase M, Yamamura H. Double-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertension. Jpn J Ophthalmol. 1993;37:514-525.
8. Toris CB, Camras CB, Yablonski ME, Brubaker RF. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv Ophthalmol. 1997;41:Suppl2, s69-s75.
9. De Arruda Mello PA, Yannoulis NC, Haque RM. Safety of unoprostone isopropyl as mono-or adjunctive therapy in patients with primary open-angle glaucoma or ocular hypertension. Drug Saf. 2002;25:583-597.
10. Taniguchi T, Haque MS, Sugiyama K, Hori N, Kitazawa Y. Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits. J Ocul Pharmacol Ther. 1996;12:489-498.
11. Serle JB, Podos SM, Kitazawa Y, Wang RF. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes. Jpn J Ophthalmol. 1998;42:95-100.
12. Ueno R, Yoshida S, Deguchi T, Kato I, Oda T, Hayashi Y, Kuno S. The intraocular pressure lowering effects of UF-021, a novel prostaglandin related compound, in animals. Nippon Ganka Gakkai Zasshi. 1992;96:462-468.
13. Sakurai M, Araie M, Oshika T, Mori M, Masuda K, Ueno R, Takase M. Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol. 1991; 35:156-165.
14. Sakurai M, Araie M, Oshika T, Mori M, Shoji N, Masuda K. Effects of topical application of UF-021, a novel prostaglandin-related compound, on aqueous humor dynamics in rabbit. Jpn J Ophthalmol. 1993;37:252-258.
15. Kashiwagi K, Iizuka Y, Tsukahara S. Metabolites of isopropyl unoprostone as potential ophthalmic solutions to reduce intraocular pressure in pigmented rabbits. Jpn J Pharmacol. 1999;81:56-62.
16. Polska E, Doelemeyer A, Luksch A, Ehrlich P, Kaehler N, Percicot CL, Lambrou GN, Schmetterer L. Partial antagonism of endothelin 1-induced vasoconstriction in the human choroid by topical unoprostone isopropyl. Arch Ophthalmol. 2002;120:348-352.
17. Makimoto Y, Sugiyama T, Kojima S, Azuma I. Long-term effect of topically applied isopropyl unoprostone on microcirculation in the human ocular fundus. Jpn J Ophthalmol. 2002;46:31-35.
18. Tamaki Y, Araie M, Tomita K, Nagahara M, Sandoh S, Tomidokoro A. Effect of topical unoprostone on circulation of human optic nerve head and retina. J Ocul Pharmacol Ther. 2001;17:517-527.
19. Sugiyama T, Azuma I. Effect of UF-021 on optic nerve head circulation in rabbits. Jpn J Ophthalmol. 1995;39:124-129.
20. Yu DY, Su EN, Cringle SJ, Schoch C, Percicot CP, Lambrou GN. Comparison of the vasoactive effects of the docosanoid unoprostone and selected prostanoids on isolated perfused retinal arterioles. Invest Ophthalmol Vis Sci. 2001;42:1499-1504.
21. Hayashi E, Yoshitomi T, Ishikawa H, Hayashi R, Shimizu K. Effects of isopropyl unoprostone on rabbit ciliary artery. Jpn J Ophthalmol. 2000;44:214-220.
22. Mulvany MJ, Halpern W. Mechanical properties of vascular smooth muscle cells in situ. Nature. 1976;260:617-619.
23. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
24. Schilling L, Kanzler C, Schmiedek P, Ehrenreich H. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin- releasing factor in the rat isolated basilar artery. Br J Pharmacol. 1998;125:1164-1171.
25. Brunner F, Schmidt K, Nielsen EB, Mayer B. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J Pharmacol Exp Ther. 1996;277:48-53.
26. Putney JW. A model for receptor-regulated calcium entry. Cell Calcium. 1986;7:1-12.
27. Yoshitomi T, Ishikawa H, Hayashi E. Pharmacological effects of pilocarpine on rabbit ciliary artery. Curr Eye Res. 2000;20:254-259.
28. Tomidokoro A, Araie M, Tamaki Y, Tomita K. In vivo measurement of iridial circulation using laser speckle phenomenon. Invest Ophthalmol Vis Sci. 1998;39:364-371.
29. Brunner F, Stessel H, Kukovetz WR. Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett. 1995;376:262-266.
30. Thieme H, Stumpff F, Ottlecz A, Percicot CL, Lambrou GN, Wiederholt M. Mechanisms of action of unoprostone on trabecular meshwork contractility. Invest Ophthalmol Vis Sci. 2001;42:3193-3201.
31. Kaczorowski GJ, Knaus HG, Leonard RJ, Mcmanus O, Garcia ML. High-conductance calcium-activated potassium channels; structure, pharmacology, and function. J Bioenerg Biomembr. 1996;28:255-267.
32. Watanabe C, Matsumoto S, Kin K, Tsuchisaka H, Ueno R. Ocular penetration of UF-021, a new prostaglandin related compound, in the rabbit eye. Nippon Ganka Gakkai Zasshi. 1992;96:335-339.
33. Mcfadzean I, Gibson A. The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle. Br J Pharmacol. 2002;135: 1-13.
34. Gustafsson H. Vasomotion and underlying mechanisms in small arteries. An in vitro study of rat blood vessels. Acta Physiol Scand Suppl. 1993;614:1-44.
35. Laporte R, Laher I. Sarcoplasmic reticulum-sarcolemma interactions and vascular smooth muscle tone. J Vasc Res. 1997;34:325-343.
36. Hughes AD. Calcium channels in vascular smooth muscle cells. J Vasc Res. 1995;32:353-370.
37. Orallo F. Regulation of cytosolic calcium levels in vascular smooth muscle. Pharmacol Ther. 1996;69:153-171.
38. 2+ entry and the regulation of smooth muscle tone. Trends Pharmacol Sci. 1998;19:266-269.
39. Wallace P, Ayman S, Mcfadzean I, Gibson A. Thapsigargin-induced tone and capacitative calcium influx in mouse anococcygeus smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol. 1999;360:368-375.